|
🐜
|
T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment.
12 auth.
J. Domínguez,
M. de Souza-Galvão,
J. Ruiz-manzano,
I. Latorre,
C. Prat,
A. Lacoma,
...
C. Milà,
M. Á. Jiménez,
S. Blanco,
J. Maldonado,
N. Altet,
V. Ausina
|
5 |
2009 |
5
🐜
|
|
🐜
|
Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children.
9 auth.
I. Latorre,
M. de Souza-Galvão,
J. Ruiz-manzano,
A. Lacoma,
C. Prat,
L. Fuenzalida,
...
N. Altet,
V. Ausina,
J. Domínguez
|
5 |
2009 |
5
🐜
|
|
🐜
|
IFN-γ-release assays to diagnose TB infection in the immunocompromised individual
7 auth.
J. Domínguez,
I. Latorre,
N. Altet,
L. Mateo,
M. de Souza-Galvão,
J. Ruiz-manzano,
...
V. Ausina
|
5 |
2009 |
5
🐜
|
|
🐜
|
Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy
9 auth.
I. Latorre,
N. Altet,
M. de Souza-Galvão,
J. Ruiz-Manzano,
A. Lacoma,
C. Prat,
...
M. Pérez,
V. Ausina,
J. Domínguez
|
3 |
2012 |
3
🐜
|
|
🐜
|
Development and Evaluation of an NTM-IGRA to Guide Pediatric Lymphadenitis Diagnosis
30 auth.
R. Villar-Hernández,
I. Latorre,
Antoni Noguera-Julián,
A. Martínez-Planas,
Laura Minguell,
Teresa Vallmanya,
M. Méndez,
A. Soriano-Arandes,
F. Baquero-Artigao,
P. Rodríguez-Molino,
Sara Guillén-Martín,
Carlos Toro-Rueda,
M. de Souza-Galvão,
M. Jiménez-Fuentes,
Zoran Stojanovic,
...
J. Sabriá,
José Santos,
Jordi Puig,
Marisol Domínguez-Álvarez,
J. Millet,
N. Altet,
Yolanda Galea,
B. Muriel-Moreno,
E. García-García,
Marc Bach-Griera,
C. Prat-Aymerich,
Esther Julián,
Jordi B Torrelles,
Carlos Rodrigo,
José Domínguez
|
1 |
2023 |
1
🐜
|
|
🐜
|
Discordance between TSTs and IFN-&ggr; release assays: the role of NTM and the relevance of mycobacterial sensitins
8 auth.
I. Latorre,
M. de Souza-Galvão,
J. Ruiz-manzano,
A. Lacoma,
C. Prat,
N. Altet,
...
V. Ausina,
J. Domínguez
|
0 |
2010 |
0
🐜
|
|
🐜
|
Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of activetuberculosis, latent infection and cured disease.
15 auth.
S. Díaz Fernández,
R. Villar-Hernández,
Z. Stojanović,
M. A. Fernandez-Sanmartin,
M. de Souza-Galvão,
G. Tolosa,
A. Sánchez-Montalvá,
J. Abad,
M. Jiménez-Fuentes,
G. Safont,
...
I. Romero,
J. Sabriá,
C. Prat,
J. Domínguez,
I. Latorre
|
0 |
2022 |
0
🐜
|
